Eelko Hak

14.0k total citations · 2 hit papers
315 papers, 9.8k citations indexed

About

Eelko Hak is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Health. According to data from OpenAlex, Eelko Hak has authored 315 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Epidemiology, 39 papers in Public Health, Environmental and Occupational Health and 37 papers in Health. Recurrent topics in Eelko Hak's work include Influenza Virus Research Studies (68 papers), Respiratory viral infections research (66 papers) and Pneumonia and Respiratory Infections (65 papers). Eelko Hak is often cited by papers focused on Influenza Virus Research Studies (68 papers), Respiratory viral infections research (66 papers) and Pneumonia and Respiratory Infections (65 papers). Eelko Hak collaborates with scholars based in Netherlands, Indonesia and Spain. Eelko Hak's co-authors include Elisabeth A. M. Sanders, Kristin L. Nichol, Andy I. M. Hoepelman, James D. Nordin, John P. Mullooly, Arno W. Hoes, K. J. Gorter, Guy E.H.M. Rutten, Maarten J. Postma and David Nelson and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Eelko Hak

302 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus

2005 743 citations Eelko Hak et al. profile →
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly

2007 497 citations Eelko Hak et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eelko Hak	5.4k	1.5k	1.1k	1.0k	740	315	9.8k
Tracy A. Lieu	5.3k 1.0×	1.7k 1.1×	2.3k 2.0×	1.5k 1.4×	962 1.3×	230	12.5k
Carlos G. Grijalva	8.2k 1.5×	2.1k 1.4×	462 0.4×	2.4k 2.4×	1.1k 1.5×	274	13.0k
Frank DeStefano	4.4k 0.8×	2.7k 1.8×	2.8k 2.5×	407 0.4×	830 1.1×	170	12.2k
Yuwei Zhu	8.3k 1.5×	2.7k 1.8×	686 0.6×	2.6k 2.5×	475 0.6×	181	10.8k
Bruce Fireman	7.2k 1.3×	1.8k 1.2×	1.6k 1.4×	2.4k 2.4×	3.2k 4.4×	251	16.9k
Douglas Fleming	5.4k 1.0×	1.4k 0.9×	441 0.4×	799 0.8×	149 0.2×	158	8.0k
John P. Mullooly	4.2k 0.8×	1.2k 0.8×	1.8k 1.6×	545 0.5×	409 0.6×	143	8.1k
Stefan Gravenstein	4.1k 0.8×	1.7k 1.1×	588 0.5×	550 0.5×	222 0.3×	212	9.0k
Mark Loeb	6.2k 1.2×	4.7k 3.1×	820 0.7×	2.1k 2.1×	361 0.5×	340	16.4k
Nicola Principi	8.8k 1.6×	3.9k 2.6×	910 0.8×	2.6k 2.6×	2.0k 2.7×	591	16.5k

Countries citing papers authored by Eelko Hak

Since Specialization

Citations

This map shows the geographic impact of Eelko Hak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eelko Hak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eelko Hak more than expected).

Fields of papers citing papers by Eelko Hak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eelko Hak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eelko Hak. The network helps show where Eelko Hak may publish in the future.

Co-authorship network of co-authors of Eelko Hak

This figure shows the co-authorship network connecting the top 25 collaborators of Eelko Hak. A scholar is included among the top collaborators of Eelko Hak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eelko Hak. Eelko Hak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bos, Jens, Brenda C. M. de Winter, Eelko Hak, et al.. (2025). ADHD medication dispensing trends in Dutch youth before and after the implementation of the Youth Act (2010–2022). European Child & Adolescent Psychiatry. 34(12). 3899–3909.

Kremer, Daan, Tim J. Knobbe, Gérard Hopfgartner, et al.. (2025). Dose, Kidney Function, and a Drug–Excipient Interaction Impair Mycophenolate Mofetil Prodrug Activation in Kidney Transplant Recipients. European Journal of Drug Metabolism and Pharmacokinetics. 50(4). 341–352.

Barrett, Jim W., et al.. (2025). Exploring the Reliability of Detecting Drug–Drug Interactions that Increase the Risk of Gestational Diabetes in Adverse Event Reporting Systems. Drug Safety. 49(2). 225–238. 1 indexed citations

Moermond, Caroline, et al.. (2024). Reducing Pharmaceuticals in Water, a New Module Integrated in the Pharmacy Game: Evaluating the Module’s Effects on Students’ Knowledge and Attitudes. SHILAP Revista de lepidopterología. 12(1). 28–28. 6 indexed citations

Bos, Jens, et al.. (2023). Switching pattern and dose adjustment of antidepressants before and during pregnancy. Archives of Women s Mental Health. 26(5). 685–696. 1 indexed citations

Schans, Jurjen van der, Samuel Bawa, Balcha Masresha, et al.. (2023). The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy. Health Economics Review. 13(1). 36–36. 5 indexed citations

Vos, Stijn de, et al.. (2023). Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study. Preventive Medicine Reports. 34. 102258–102258. 2 indexed citations

Feenstra, Talitha, et al.. (2023). The Association between Deductibles and Cardiovascular Medication Adherence: A Retrospective Inception Cohort Study. Drugs - Real World Outcomes. 11(1). 99–108.

Vos, Stijn de, et al.. (2023). Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus. Pharmacoepidemiology and Drug Safety. 32(12). 1395–1405. 3 indexed citations

10.

Emmens, Johanna E., Stijn de Vos, Jens Bos, et al.. (2022). Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative. Utrecht University Repository (Utrecht University). 14 indexed citations

11.

Klont, Frank, Daan Kremer, Tim J. Knobbe, et al.. (2022). Assessing the Potential of Untargeted SWATH Mass Spectrometry-Based Metabolomics to Differentiate Closely Related Exposures in Observational Studies. Metabolites. 12(10). 942–942. 4 indexed citations

12.

Vos, Stijn de, et al.. (2022). Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study. Cardiovascular Therapeutics. 2022. 1–9. 3 indexed citations

13.

Alfian, Sofa D., Job F. M. van Boven, Jutti Levita, et al.. (2022). Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials. Journal of Medical Internet Research. 24(2). e33062–e33062. 55 indexed citations

14.

Klont, Frank, Daan Kremer, António W. Gomes‐Neto, et al.. (2021). Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors. Journal of Clinical Epidemiology. 135. 10–16. 10 indexed citations

15.

Minović, Isidor, Lyanne M. Kieneker, Ron T. Gansevoort, et al.. (2020). Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study. Nutrients. 12(9). 2711–2711. 12 indexed citations

16.

Kerr, Karen, et al.. (2020). Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review. Diabetic Medicine. 38(2). e14408–e14408. 36 indexed citations

17.

Denig, Petra, et al.. (2019). Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PLoS ONE. 14(3). e0214240–e0214240. 51 indexed citations

18.

Hak, Eelko, et al.. (2018). A Retrospective Surveillance of the Antibiotics Prophylactic Use of Surgical Procedures in Private Hospitals in Indonesia. Hospital Pharmacy. 54(5). 323–329. 16 indexed citations

19.

Schuiling‐Veninga, Catharina C. M., et al.. (2013). Prenatal exposure to acid‐suppressive drugs and the risk of allergic diseases in the offspring: a cohort study. Clinical & Experimental Allergy. 44(2). 261–269. 28 indexed citations

20.

Hak, Eelko, et al.. (2010). Influenza vaccination of hospital healthcare staff from the perspective of the employer:a positive balance. University of Groningen research database (University of Groningen / Centre for Information Technology). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact